Impact of Enhanced Recovery After Surgery (ERAS) Guidelines Implementation in Cesarean Delivery: A Systematic Review and Meta-Analysis

Abstract

Background: Cesarean delivery rate is increasing, with no prediction of this rate to drop. Implementation of Early Recovery After Surgery (ERAS) program adapted to this high prevalent obstetrical surgical procedure proposes better peri-operative care achievement with improved maternal medical care, namely reduced morbidity, faster return to normal daily activities and improved impact on quality of life. Our aim was to analyze the outcomes of ERAS guidelines implementation in cesarean sections (CS). Material and methods: A systematic review was performed across 3 databases (MEDLINE (Pubmed), Scopus and Web of Science), with no time or language filters, for articles comparing outcomes on pregnant women who delivered via CS with ERAS guidelines implementation versus the traditional approach without ERAS implementation. Outcomes established: primary - hospital length of stay; secondary - opioid consumption, readmission rates and maternal complications (overall, surgical site infection and emetic morbidity). Statistical analyses were conducted using Review Manager 5.4 and its results were expressed as mean difference, standardized mean difference and odds ratio, with 95% of confidence intervals. This systematic review was reported according to the PRISMA statement. Results: This systematic review included 16 studies (3 randomized controlled trials (RCT), 4 prospective cohorts and 9 retrospective cohorts), with a pool analysis of 19001 women (9752 with the traditional approach and 9249 following ERAS guidelines). Our results showed a significative decrease in length of hospital stay (MD: -13.78h; CI 95% -19.28 to -8.28; p<0.00001) and opioid consumption (SMD: -0.91; CI 95% -1.51 to -0.32; p=0.003), with similar readmission rates (OR: 0.85; CI 95% 0.50 to 1.44; p=0.53) and maternal complications, namely: overall (OR: 0.87; CI 95% 0.56 to 1.35; p=0.53); surgical site infection (OR: 1.13; CI 95% 0.72 to 1.77; p=0.60) and emetic morbidity (OR: 0.78; CI 95% 0.31 to 1.96; p=0.60). Conclusions: ERAS guidelines applied at CS management are associated with decreased length of stay and opioid consumption, without negatively impact on readmission rates and overall maternal complications, including surgical site infection and emetic morbidity. The reduced number of RCT studies and the heterogeneity of the studies (heterogeneous inter-study protocols) constitutes the major limitation of the evidence found. Still, these findings may be a foremost help to confirm the beneficial impact of an ERAS approach during peri-cesarean management. KEYWORDS: ERAS; Enhanced Recovery After Surgery; Cesarean Section; Maternal Outcomes